Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis. (2018). Farmeconomia. Health Economics and Therapeutic Pathways, 19(1). https://doi.org/10.7175/fe.v19i1.1385